a16z Capital Management, L.L.C.
Position in CAMP — Camp4 Therapeutics Corp
CIK 1540358
MENLO PARK, CA
Position in CAMP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,372,744
-$3,655,584 QoQ
Shares Held
2,125,339
0.0% QoQ
Ownership
4.09%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#7
of 46 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CAMP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026a16z Capital Management, L.L.C. holds $304,679,821 across 8 Biotechnology names. CAMP ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
921,099 | $89,576,877 | |
| 2 | NAUT |
Nautilus Biotechnology, Inc.
|
17,653,917 | $68,497,197 | |
| 3 | MAZE |
Maze Therapeutics, Inc.
|
1,702,225 | $50,811,416 | |
| 4 | ERAS |
Erasca, Inc.
|
2,862,500 | $46,315,250 | |
| 5 | DMRA |
Damora Therapeutics, Inc.
|
1,236,157 | $32,016,466 | |
| 6 | CAMP |
Camp4 Therapeutics Corp
This page
|
2,125,339 | $9,372,744 | |
| 7 | AKTS |
Aktis Oncology, Inc.
|
415,000 | $7,424,350 | |
| 8 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
108,568 | $665,521 |
All Filings in CAMP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,372,744 | 2,125,339 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,028,328 | 2,125,339 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,376,017 | 2,125,339 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,081,741 | 2,125,339 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,501,356 | 2,125,339 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,094,269 | 2,125,339 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||